Loading
Calumet, Inc. /DE Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest was filed 05 Mar 2025.
Calumet, Inc. /DE: what insiders have been doing
Headquartered in Indianapolis, Calumet, Inc. /DE belongs to the Chemicals & Materials sector and traces its origins to 1916. Filings by its managers are published through SEC (Form 4). From 18 October 2025 to 18 October 2026, the disclosure feed for Calumet, Inc. /DE logged 38 filings by 15 insiders.
There is no open-market purchase to report; the filings show 3 sales worth €362k by 2 insiders. No amount is published for 1 filing, which the totals therefore leave out. At €264k, the sale published on 26 February 2026 by Sajkowski Daniel J is the largest of the period (0.0073% of market cap).
With 38 filings in twelve months, the company is more active than the median of 19 filings across the 5,811 companies we follow on the same exchange. The full history, which starts in 2024, counts 1 purchase against 13 sales. The 10-K for the year ended 31 December 2025 shows 4.14 bn USD of revenue and -33.8 m USD of net income.
The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.
For comparison within the same sector, see the insider buying recorded at Culp Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
73
Thresholds
n/a
Buy Volume
€31,116
1 ops. · all time
Sell Volume
€7M
13 ops. · all time
Who traded when
BuySaleStraumins Jennifer5 sales
Stephen P. Mawer4 sales
Daniel J. Sajkowski2 sales
Gregory J. Morical1 sale
Lunin David1 buy
Sheets Daniel L1 sale
Since the insiders bought
- +144.2%Entry US$12.45 · Close at T+365 US$30.40
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Calumet, Inc. /DE Buy (bullish), based on 5 analysts. Average price target: US$53.40.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 22,272 of 24,158 companies
19.7
score / 100
Value28
Quality12
FCF yld1.1%
Earn yld-0.7%
EV/EBITDA31.6x
ROE·
Gross mgn5.9%
Net mgn-0.8%
Debt/EBITDA10.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$57.53
Analyst consensus
5 analystsBuy
US$40.00Target US$53.40(-7%)US$75.00
Income statement
RevenueUS$4.1B
Gross profitUS$245.7M6% margin
EBITDAUS$238.2M6% margin
Net income-US$33.8M-3.0% margin
Valuation
PER (forward)91.3x
Beta0.78
Balance sheet & cash
Market capUS$5.1B
Total debtUS$2.5B
Free Cash FlowUS$56.6M
Profitability & ownership
ROA-1.3%
% insiders20.1%
% institutions51.9%
Last declaration on 28 September 2026
Declarations73 total
46,901 shares0Common Stock, par value $0.01 per shareSEC:0001823742-26-000005:1
30,694 shares0Common Stock, par value $0.01 per shareSEC:0002003802-26-000005:0
107,428 shares0Common Stock, par value $0.01 per shareSEC:0001823742-26-000005:0
61,387 shares0Common Stock, par value $0.01 per shareSEC:0001669531-26-000007:0
24,555 shares0Common Stock, par value $0.01 per shareSEC:0001669531-26-000007:1
107,428 shares0Common Stock, par value $0.01 per shareSEC:0001670422-26-000005:0
42,190 shares0Common Stock, par value $0.01 per shareSEC:0001670422-26-000005:1
13,560 shares0Common Stock, par value $0.01 per shareSEC:0002003802-26-000005:1
7,067 shares0Common Stock, par value $0.01 per shareSEC:0001628280-26-048015:0
7,067 shares0Common Stock, par value $0.01 per shareSEC:0001628280-26-048021:0
2,827 shares0Common Stock, par value $0.01 per shareSEC:0001628280-26-048021:1
7,067 shares0Common Stock, par value $0.01 per shareSEC:0001628280-26-047990:0
7,067 shares0Common Stock, par value $0.01 per shareSEC:0001628280-26-047994:0
7,067 shares0Common Stock, par value $0.01 per shareSEC:0001628280-26-047998:0
7,067 shares0Common Stock, par value $0.01 per shareSEC:0001628280-26-048009:0
2,827 shares0Common Stock, par value $0.01 per shareSEC:0001628280-26-048015:1
7,067 shares0Common Stock, par value $0.01 per shareSEC:0001628280-26-048017:0
2,827 shares0Common Stock, par value $0.01 per shareSEC:0001628280-26-048017:1
13,780 shares0Common Stock, par value $0.01 per shareSEC:0001628280-26-048019:0
5,512 shares0Common Stock, par value $0.01 per shareSEC:0001628280-26-048019:1
4,240 shares@ US$36.020.0032% mcap100.0% of flowCommonSEC144:0001950047-26-006764
540,000 shares0Common StockSEC:0001193125-26-259704:0
3,310 shares@ US$34.460.0027% mcap27.2% of flowCommon Stock, par value $0.01 per shareSEC:0001619678-26-000005:0
15,348 shares0Common Stock, par value $0.01 per shareSEC:0002003802-26-000002:0
24,090 shares0Common Stock, par value $0.01 per shareSEC:0001801826-26-000002:0
25 of 73 declarations
About Calumet, Inc. /DE
Calumet, Inc. /DE is a U.S.-based industrial company listed on the NASDAQ under the ticker CLMT and domiciled in the United States. For international investors, it is best viewed as a niche energy-and-specialty-materials platform that combines specialty refining, branded performance products, and renewable fuels. The company is headquartered in Indianapolis, Indiana, and states that it operates twelve facilities across North America. Calumet traces its roots back to 1919, giving it more than a century of operating history in downstream hydrocarbons and specialty formulations. ([sec.gov](https://www.sec.gov/Archives/edgar/data/2013745/000201374526000007/clmt-20251231x10k.htm?utm_source=openai))
Calumet’s business model is organized around three core segments. Specialty Products and Solutions manufactures and markets a broad portfolio of solvents, waxes, customized lubricating oils, white oils, petrolatums, gels, esters, and related products. These products are sold mainly to industrial customers and into downstream consumer-facing supply chains, where formulation quality, consistency, and application-specific performance matter more than commodity branding. Performance Brands covers well-known consumer and professional brands such as Royal Purple, Bel-Ray, and TruFuel, and focuses on blending, packaging, and marketing premium automotive and performance products. Montana/Renewables includes a renewable fuels facility and a specialty asphalt operation in Montana, with production centered on renewable diesel, sustainable aviation fuel (SAF), and renewable naphtha. ([sec.gov](https://www.sec.gov/Archives/edgar/data/2013745/000201374526000007/clmt-20251231x10k.htm?utm_source=openai))
Read moreShow less
From a competitive standpoint, Calumet sits in a differentiated niche rather than in a pure commodity business. Its specialty products benefit from technical know-how, formulation expertise, and long-standing customer relationships, while its renewables platform gives it exposure to a structurally attractive growth theme. At the same time, that renewables exposure also makes earnings sensitive to policy incentives, regulatory credits, feedstock economics, and refining spreads. The company serves both domestic and international customers, with North American manufacturing and sales as the core base and some international reach in specialty products. ([sec.gov](https://www.sec.gov/Archives/edgar/data/2013745/000201374526000007/clmt-20251231x10k.htm?utm_source=openai))
Recent developments have been strategically important. In 2024, Calumet completed its conversion from a partnership structure into a C-corporation, an event that materially changed its capital-market profile and simplified the equity story. In February 2025, Montana Renewables received its first drawdown of roughly $782 million under a DOE-guaranteed loan facility to fund its expansion, with management targeting a significant increase in SAF capacity over time. Calumet also announced the sale of the industrial portion of Royal Purple for $110 million, while retaining the consumer business and the Porter, Texas manufacturing site, with proceeds intended primarily for debt reduction. Together, these actions underscore a clear strategic priority: deleveraging the balance sheet while scaling the company’s renewable-fuels footprint and protecting its specialty-products moat. ([nasdaq.com](https://www.nasdaq.com/press-release/calumet-reports-fourth-quarter-and-fiscal-year-2024-results-2025-02-28))
For French-speaking investors, Calumet is a relatively complex but interesting listed name on the U.S. NASDAQ market. It combines cyclical exposure, regulatory complexity, and a long-dated transformation story. The key items to watch remain execution in renewables, margin resilience in specialty products, and the pace of balance-sheet repair. ([sec.gov](https://www.sec.gov/Archives/edgar/data/2013745/000201374526000007/clmt-20251231x10k.htm?utm_source=openai))
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
